Publications by authors named "Michael McEntee"

Claim this Profile
E
Erythema multiforme associated with zonisamide in a dog.
Amanda L Ackermann, Linda A Frank, Michael F McEntee, Elizabeth R May

Vet Dermatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.
Raymond Y Wang, Afshin Aminian, Michael F McEntee, Shih-Hsin Kan, Calogera M Simonaro

Mol Genet Metab· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity.
Amanda J MacFarlane, Michael F McEntee, Patrick J Stover

J Nutr· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells.
E-Chu Huang, Yi Zhao, Guoxun Chen, Seung Joon Baek, Michael F McEntee

BMC Complement Altern Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid.
Xiaobo Zhang, Seong-Ho Lee, Kyung-Won Min, Michael F McEntee, Jin Boo Jeong

Cancer Prev Res (Phila)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer.
E-Chu Huang, Michael F McEntee, Jay Whelan

Nutr Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropometric variables accurately predict dual energy x-ray absorptiometric-derived body composition and can be used to screen for diabetes.
Reza Yavari, Erin McEntee, Michael McEntee, Michael Brines

PLoS One· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.
E-Chu Huang, Guoxun Chen, Seung Joon Baek, Michael F McEntee, J Jason Collier

Nutr Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidase.
Agnes Chen, Carole Vogler, Michael McEntee, Stephen Hanson, N Matthew Ellinwood

APMIS· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy.
Kim M Newkirk, Rosalie M Atkins, Patti I Dickson, Barton W Rohrbach, Michael F McEntee

Invest Ophthalmol Vis Sci· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial pathology in canine mucopolysaccharidosis-I and response to therapy.
Jeremiah A Lyons, Patricia I Dickson, Jonathan S Wall, Merry B Passage, N Matthew Ellinwood, Michael F McEntee

Lab Invest· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mthfd1 is a modifier of chemically induced intestinal carcinogenesis.
Amanda J MacFarlane, Cheryll A Perry, Michael F McEntee, David M Lin, Patrick J Stover

Carcinogenesis· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.
Amanda J Macfarlane, Cheryll A Perry, Michael F McEntee, David M Lin, Patrick J Stover

Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.
Patricia I Dickson, Stephen Hanson, Michael F McEntee, Charles H Vite, Carole A Vogler

Mol Genet Metab· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.
Ashley D Dierenfeld, Michael F McEntee, Carole A Vogler, Charles H Vite, Agnes H Chen

Sci Transl Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCC-555-induced NAG-1 expression is mediated in part by KLF4.
Maria Cekanova, Seong-Ho Lee, Michael F McEntee, Seung Joon Baek

Eur J Pharmacol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.
Kiyoshi Yamaguchi, Maria Cekanova, Michael F McEntee, Joo-Heon Yoon, Susan M Fischer

Mol Cancer Ther· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.
Patricia Dickson, Maryn Peinovich, Michael McEntee, Thomas Lester, Steven Le

J Clin Invest· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer.
Michael F McEntee, Carol Ziegler, Danielle Reel, Kenneth Tomer, Ahmed Shoieb

Am J Pathol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer.
Mugdha Sukhthankar, Kiyoshi Yamaguchi, Seong-Ho Lee, Michael F McEntee, Thomas E Eling

Gastroenterology· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid.
Patricia Dickson, Michael McEntee, Carole Vogler, Steven Le, Beth Levy

Mol Genet Metab· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice.
Jung Han Kim, Taryn P Stewart, Morvarid Soltani-Bejnood, Luan Wang, Jennifer M Fortuna, Michael F McEntee

J Endocrinol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia.
Seung Joon Baek, Ryuji Okazaki, Seong-Ho Lee, Jeanelle Martinez, Jong-Sik Kim, Michael F McEntee

Gastroenterology· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
Yuseok Moon, Frank G Bottone, Michael F McEntee, Thomas E Eling

Mol Cancer Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary (n-6) PUFA and intestinal tumorigenesis.
Jay Whelan, Michael F McEntee

J Nutr· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis